Molecular Pharmaceutics · 2016 · 26 citations · 33 references
MedicinePharmacokineticsPharmacologyDrug MetabolismMetabolismPharmacokinetic ModelingCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesEnzyme InhibitionEnzyme KineticsTime-dependent KineticsCytochrome P450 3A4 MetabolismCytochrome P450 Enzyme InhibitionCytochrome P450 KineticsMechanism-based Enzyme InhibitionMechanism-based InhibitionRat Liver MicrosomesTime-dependent Enzyme InhibitionTime-dependent Inhibition
An in vitro observation of time-dependent inhibition (TDI) of metabolic enzymes often results in removing a potential drug from the drug pipeline. However, the accepted method for predicting TDIs of the important drug metabolizing cytochrome P450 enzymes often overestimates the drug interaction potential. Better models that take into account the complexities of the cytochrome P450 enzyme system will lead to better predictions. Herein we report the use of our previously described models for complex kinetics of podophyllotoxin. Spectral characterization of the kinetics indicates that an intermediate MI complex is formed, which slowly progresses to an essentially irreversible MI complex. The intermediate MI complex can release free enzyme during the time course of a typical 30 min TDI experiment. This slow rate of MI complex conversion results in an overprediction of the kinact value if this process is not included in the analysis of the activity versus time profile. In vitro kinetic experiments in rat liver microsomes predicted a lack of drug interaction between podophyllotoxin and midazolam. In vivo rat pharmacokinetic studies confirmed this lack of drug interaction.
33
Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4
Yune‐Fang Ueng, Takashi Kuwabara, Young‐Jin Chun et al. · Biochemistry · 1997 · 386 citations